All In Biotech

Drug Trial Radar · NCT06591845

Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

A Single-Center, Randomized, Partially Double-Blind, Placebo- and Active-Controlled, Four-period Crossover, Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

34

Actual

Start

Sep 25, 2024

Primary completion

Dec 16, 2024

Study completion Dec 23, 2024

Sponsor

Sponsor type
Industry
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a single-center, randomized, partially double-blind, placebo and active-controlled, 4-period crossover design thorough QT/QTc (TQT) clinical study to evaluate the effects of ziresovir on cardiac repolarization in healthy subjects.

Conditions

  • Healthy Volunteers

Interventions

  • Ziresovir 125 mgDrug

    Active Substance: Ziresovir, Pharmaceutical Form: Suspension, Route of Administration: Oral

  • Ziresovir 500 mgDrug

    Active Substance: Ziresovir, Pharmaceutical Form: Suspension, Route of Administration: Oral

  • PlaceboDrug

    Active Substance: Placebo, Pharmaceutical Form: Suspension, Route of Administration: Oral

  • Moxifloxacin hydrochloride tablet 400 mgDrug

    Active Substance: Moxifloxacin hydrochloride Pharmaceutical Form: Tablet Route of Administration: Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline QTcF (ΔQTcF)Time frame: Before dosing (Baseline) through 48 hours after the dose on Day 1 in each treatment period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • California Clinical Trials Medical Group, Inc.

    Glendale, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.